BioLizard appoints Paul Vauterin as Chief Technology Officer

BioLizard appoints Paul Vauterin as Chief Technology Officer to strengthen its leadership team. With deep expertise in data analytics and software architecture for life sciences, Paul will help BioLizard advance data-driven R&D, digital transformation, and innovative solutions for biotech and pharma.

Ghent, 30th March, 2023.

We are excited to announce the appointment of Paul Vauterin as Chief Technology Officer. The company has expanded rapidly in the last 2 years and this new position in the leadership team will help BioLizard continue and solidify this growth.

BioLizard supports biotech and pharma companies to make discovery and R&D truly data-driven by leveraging the power of bioinformatics, data science, software development and data management. Paul Vauterin’s extensive experience in data analytics and software architecture for life science and biotech applications make him a perfect fit for BioLizard’s leadership team. Paul has worked on every aspect of the software product life cycle, and his expertise will be invaluable in helping BioLizard help their customers leverage the full potential of data for life sciences and health care.

Throughout my entire career, my passion has been to leverage the full potential of data for life sciences and health care. Therefore I’m thrilled to join BioLizard, a company that has become a leader in supporting digital transformation for pharma and biotech. In my role as CTO, I hope to help BioLizard take the next steps of this fantastic journey, and in that way contribute to improving patients’ lives.

Paul Vauterin
BioLizard – CTO

About BioLizard

BioLizard is an agile data analytics and data management consulting company, and a leader in supporting digital transformation in the life sciences industry. The company specializes in the handling of complex scientific data and the application of state-of-the-art technologies for data-driven R&D, drug and biomarker development, healthcare and other applications – all with the goal of helping life science companies get the most out of their scientific data.

The complementary team of Lizards consists of computer scientists, IT architects, data engineers, bioinformaticians, biostatisticians, software developers, and computational biologists, bringing together a broad expertise to tackle all data-related needs and challenges relevant to the life sciences industry.

How spatial biology improves clinical trial success in oncology

How spatial biology improves clinical trial success in oncology

In oncology, the drug development path is unique: Phase 0 and Phase I trials are typically conducted in patients rather than healthy volunteers, allowing for early assessment of efficacy and patient selection alongside safety. Yet, even with this early clinical insight, many cancer drugs show promise in the lab but fail to transition effectively into the clinic. This often happens because, while we verify that a drug’s target is present, we frequently overlook its context, specifically its location, the surrounding microenvironment, and its interaction with neighboring cells. By revisiting real-world examples of discontinued trials, this post explains why understanding the “where” is just as critical as the “what”, and how spatial biology is positioning itself as a valuable avenue for validating clinical potential.

Why bioinformatics workflows require experienced software engineers

Bioinformatics pipelines break for the smallest reasons: package updates, shifting dependencies, or “it only works on my machine.” This post explains why experienced software engineers and DevOps practices (Git, CI/CD, IaC) are essential to keep workflows reproducible, stable, and scalable.